Soft Tissue Repair Market report
analyses the prospects in the market for several shareholders and aspirants by
identifying the high-growth segments, main actions approved by them and Soft
Tissue Repair market recent progressions. The Soft Tissue Repair market report
is prepared after fundamental levels of research regarding the Soft Tissue
Repair Industry.
Global Soft Tissue Repair Market is anticipated to reach $25,635
million by 2025, growing at a CAGR of 5.6%. The fixation devices segment
accounted for one-fifth share of the global market revenue in 2017.
Soft tissue injuries are trauma caused to muscles, ligaments,
and tendons. Tendons are fibrous connective tissues that attach muscles to a
bone. The damage caused by overstressing of muscles or tendons is known as
strain. Whereas, ligaments are fibrous bands that connect bones to other bones.
The injury caused due to overstretching or tearing of ligaments is called as
sprain.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/684
The key players operating in the global soft tissue repair
market are
·
Allergan Plc. (LifeCell Corporation)
·
Athersys Inc.
·
CryoLife Inc.
·
Integra Lifesciences Corporation
·
Medtronic Plc.
·
Organogenesis Inc.
·
Stryker Corporation
·
Zimmer Biomet Holdings Inc.
·
Smith & Nephew plc. and Becton
·
Dickinson and Company (C.R. Bard)
·
The other players operating in the value chain are Lifenet
Health, Inc., American Medical Systems Inc., U.S. Stem Cell, Inc. (Bioheart,
Inc.), Wright Medical Group, Inc., Isto Biologics (Isto Biologics Medical
Systems, Inc.).
Factors that drive the soft tissue repair market are surge in
obese population and increase in geriatric population. However, the high cost
associated with soft tissue repairs and lack of reimbursement are the factors
projected to restrain the market growth. Moreover, the untapped potential of
soft tissue repairs in developing countries, such as India, China, and Brazil,
is anticipated to create lucrative opportunities for the key market players.
Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/684
Based on type, the laparoscopic instrument segment accounted for
about three-sevenths share of the global market in 2016 owing to the increase
in minimally invasive surgeries and laparoscopic procedures globally.
By application, the hernia repair segment accounted for the
highest share in the global market owing to the rise in hernia cases. For instance,
at least 2% of men suffer from hernia in the U.S., i.e., 15 individuals per
1000 population suffer from various forms of hernia.
For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/684
Key Findings of the Soft Tissue Repair Market:
- The tissue mesh segment accounted for
three-eighths revenue share of the total market in 2017, and is expected
to register a CAGR of 5.8% during the forecast period.
- Biological mesh segment accounted for
about half share of the global market in 2017 and is expected to garner a
high CAGR of 6.0% during the forecast period.
- Dental repair segment is expected to grow
at a higher CAGR of 6.4% during the forecast period.
- U.S. dominated the North America soft
tissue repair market and is projected to retain its trend throughout the
forecast period.
- China is expected to exhibit highest growth
in the Asia-Pacific soft tissue repair market, registering a CAGR of 12.6%
during the forecast period.
- Saudi Arabia is expected to exhibit
highest growth in the LAMEA soft tissue repair market, registering a CAGR
of 9.8% during the forecast period.
In 2017, North America was the highest contributor to the market
in terms of revenue, owing to the increase in the wellness trend and the early
adoption of novel technologies in this sector. However, Asia-Pacific is
expected to witness the highest CAGR during the forecast period, owing to the
presence of high-populace countries, such as India and China.
No comments:
Post a Comment